Ultragenyx Pharmaceutical Inc. Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2019 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Payment of Exercise | F | 57.18 | 433 | 24,759 | 15,985 | 16.4 K to 16 K (-2.64 %) |
| May 22 2019 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Payment of Exercise | F | 59.50 | 156 | 9,282 | 16,418 | 16.6 K to 16.4 K (-0.94 %) |
| May 22 2019 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 59.50 | 1,414 | 84,133 | 468,806 | 470.2 K to 468.8 K (-0.30 %) |
| May 22 2019 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Payment of Exercise | F | 59.50 | 381 | 22,670 | 90,587 | 91 K to 90.6 K (-0.42 %) |
| May 22 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Payment of Exercise | F | 59.50 | 381 | 22,670 | 67,592 | 68 K to 67.6 K (-0.56 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Grant | A | 0.00 | 1,434 | 0 | 67,973 | 66.5 K to 68 K (+2.16 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Grant | A | 0.00 | 1,434 | 0 | 38,613 | 37.2 K to 38.6 K (+3.86 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 1,434 | 0 | 21,014 | 19.6 K to 21 K (+7.32 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Grant | A | 0.00 | 3,435 | 0 | 470,220 | 466.8 K to 470.2 K (+0.74 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 1,438 | 0 | 24,802 | 23.4 K to 24.8 K (+6.15 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | VP, Controller and ... | Grant | A | 0.00 | 800 | 0 | 16,574 | 15.8 K to 16.6 K (+5.07 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Grant | A | 0.00 | 1,434 | 0 | 90,968 | 89.5 K to 91 K (+1.60 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 1,434 | 0 | 22,405 | 21 K to 22.4 K (+6.84 %) |
| May 07 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Payment of Exercise | F | 67.99 | 649 | 44,126 | 20,971 | 21.6 K to 21 K (-3.00 %) |